Trwa ładowanie...
d2um0pr
d2um0pr
espi

SOPHARMA AD - Current report 125 buy back 26092013 (125/2013)

SOPHARMA AD - Current report 125 buy back 26092013 (125/2013)
Share
d2um0pr
POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 125 / 2013
Date of issue: 2013-09-26
Short name of the issuer
SOPHARMA AD
Subject
Current report 125 buy back 26092013
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
SOPHARMA AD (the ?Company") hereby informs that from 19 September 2013 up to and including 25 September 2013 the Company bought 14 524 own shares representing 0.011 % of the share capital of the Company, to the total value of 47 714.54 BGN on the Bulgarian Stock Exchange. The average price per share was 3.29 BGN. The shares have been bought on the basis of decision No. 7 of the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 234 246, representing 3.97% of the share capital of the Company.
Annexes
File Description
Current report 125 buy back 26092013.doc Current report 125 buy back 26092013

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2013-09-26 Ognian Donev Executive director

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

d2um0pr

Podziel się opinią

Share
d2um0pr
d2um0pr